Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Material Management Information related to Judgment of Investment(Approval for IND Modification)(í°ííìì¹ë£ì  ì ë°ëíì ìì3ì(ì¶ê° ìì) ìììí ê³í ë³ê²½ì¹ì¸)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mezzion Pharma (140410 KS)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Material Management Information related to Judgment of Investment(Approval for IND Modification)(í°ííìì¹ë£ì ì ë°ëíì ìì3ì(ì¶ê° ìì) ìììí ê³í ë³ê²½ì¹ì¸)

Outcomes of Annual Meeting of Shareholders

[Revised] Submission of Audit Report

Submission of Audit Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Material Management Information related to Judgment of Investment(Approval for IND Modification)(í°ííìì¹ë£ì  ì ë°ëíì ìì3ì(ì¶ê° ìì) ìììí ê³í ë³ê²½ì¹ì¸)

Outcomes of Annual Meeting of Shareholders

[Revised] Submission of Audit Report

Submission of Audit Report

Material Management Information related to Judgment of Investment(Approval for IND Modification)(í°ííìì¹ë£ì ì ë°ëíì ìì3ì(ì¶ê° ìì) ìììí ê³í ë³ê²½ì¹ì¸)